| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | |
Gross Profit
|
-
|
-
|
-
| |
|
Operating Expenses |
|
Research Development | 1,092 | 2,315 | 3,106 |
|
Selling General and Administrative | 3,227 | 5,046 | 6,069 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(4,319)
|
(7,361)
|
(9,175)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 2 | 2,002 | 763 |
|
Earnings Before Interest And Taxes | (4,317) | (5,359) | (8,412) |
|
Interest Expense | 3 | 5 | 8 |
|
Income Before Tax | (4,320) | (5,364) | (8,420) |
|
Income Tax Expense |
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (4,320) | (5,364) | (8,420) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(4,320)
|
(5,364)
|
(8,420)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(4,320)
|
(5,364)
|
(8,420)
|
|